Reata Pharmaceuticals Inc financial data

Industry
Pharmaceutical Preparations
Location
5320 Legacy Drive, Plano, Texas
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2023 - Aug 8, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 545 % -38.4%
Return On Equity 335 %
Return On Assets -17.1 % +61.1%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 834M USD -78.4%
Weighted Average Number of Shares Outstanding, Basic 37.7M shares +3.3%
Weighted Average Number of Shares Outstanding, Diluted 41.5M shares +13.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.5M USD +135%
Research and Development Expense 203M USD +26.9%
General and Administrative Expense 109M USD +10.4%
Nonoperating Income (Expense) 265M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.7M USD +71.2%
Income Tax Expense (Benefit) -55K USD -122%
Net Income (Loss) Attributable to Parent -87.6M USD +71.2%
Earnings Per Share, Basic -2.51 USD/shares +70%
Earnings Per Share, Diluted -2.98 USD/shares +64.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.8M USD -66.8%
Marketable Securities, Current 281M USD -15.8%
Accounts Receivable, after Allowance for Credit Loss, Current 22.7M USD
Inventory, Net 2.94M USD
Assets, Current 402M USD -18.2%
Property, Plant and Equipment, Net 11.3M USD +2.45%
Operating Lease, Right-of-Use Asset 78.6M USD -39.1%
Other Assets, Noncurrent 499K USD +239%
Assets 503M USD -20.4%
Accounts Payable, Current 19.9M USD +156%
Accrued Liabilities, Current 25.1M USD +76.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 125M USD +170%
Operating Lease, Liability, Noncurrent 90.4M USD -32.7%
Other Liabilities, Noncurrent 5K USD -99.9%
Retained Earnings (Accumulated Deficit) -1.49B USD -6.25%
Stockholders' Equity Attributable to Parent 87.3M USD +27.2%
Liabilities and Equity 503M USD -20.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -81.4M USD -40%
Net Cash Provided by (Used in) Financing Activities 13.1M USD +6643%
Net Cash Provided by (Used in) Investing Activities 111M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 42.6M USD
Deferred Tax Assets, Valuation Allowance 424M USD +14.9%
Deferred Tax Assets, Gross 448M USD +12.2%
Operating Lease, Liability 92.9M USD -34.8%
Depreciation 1.13M USD -7.6%
Payments to Acquire Property, Plant, and Equipment 141K USD -51%
Lessee, Operating Lease, Liability, to be Paid 228M USD -3.6%
Property, Plant and Equipment, Gross 27.5M USD +2.26%
Operating Lease, Liability, Current 2.46M USD -70.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.3M USD +92.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.7M USD -27.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +92.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 135M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.6M USD +5.98%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD +17.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.8M USD
Operating Lease, Payments 3.9M USD +388%
Deferred Tax Assets, Net of Valuation Allowance 24.2M USD -20.4%
Share-based Payment Arrangement, Expense 87.8M USD +51%
Interest Expense 1.31M USD